MarketCap
Facebook
X
Telegram
PolyPid Ltd. Current Ratio | PYPD
Current Ratio Jährlich PolyPid Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 24.7 | 11.9 | 0.151 | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 24.7 | 0.151 | 12.3 |
Current Ratio anderer Aktien in der Pharmaeinzelhändler
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
3.68 | $ 516.39 | -1.44 % | $ 132 B |  USA |
 |
Burford Capital Limited
BUR
|
1.89 | $ 3.24 | -3.72 % | $ 710 M |  Britain |
 |
Catalyst Biosciences
CBIO
|
6.97 | $ 12.77 | -0.39 % | $ 1.14 B | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.94 | $ 25.47 | 1.29 % | $ 1.19 B | USA |
 |
Anika Therapeutics
ANIK
|
14.4 | $ 21.19 | -1.07 % | $ 304 M | USA |
 |
Editas Medicine
EDIT
|
1.17 | $ 2.4 | 0.05 % | $ 213 M | USA |
 |
Evogene Ltd.
EVGN
|
2.48 | $ 0.37 | 0.44 % | $ 2.91 M |  Israel |
 |
EyePoint Pharmaceuticals
EYPT
|
6.29 | $ 0.36 | -10.09 % | $ 26.4 K | USA |
 |
Fortress Biotech
FBIO
|
1.5 | $ 1.87 | -3.11 % | $ 52.2 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
2.01 | $ 10.12 | 0.4 % | $ 289 M | USA |
 |
Foghorn Therapeutics
FHTX
|
0.646 | $ 2.04 | 2.0 % | $ 128 M | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
3.16 | $ 13.76 | 4.13 % | $ 11.5 B |  India |
 |
Arcturus Therapeutics Holdings
ARCT
|
4.74 | $ 9.91 | 0.71 % | $ 271 M | Israel |
 |
Sanofi
SNY
|
2.23 | $ 41.77 | 0.41 % | $ 51 B |  France |
 |
Arcutis Biotherapeutics
ARQT
|
1.78 | $ 31.74 | 1.73 % | $ 4.04 B | USA |
 |
Geron Corporation
GERN
|
1.66 | $ 1.15 | 2.23 % | $ 767 M | USA |
 |
Gossamer Bio
GOSS
|
0.584 | $ 9.2 | -4.27 % | $ 2.1 B | USA |
 |
Titan Pharmaceuticals
TTNP
|
6.05 | - | -3.76 % | $ 3.47 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
2.19 | - | 3.16 % | $ 1.9 M | USA |
 |
ALX Oncology Holdings
ALXO
|
1.79 | $ 1.14 | -2.56 % | $ 61.2 M | USA |
 |
Heron Therapeutics
HRTX
|
1.06 | $ 0.3 | -0.46 % | $ 50 M | USA |
 |
Achieve Life Sciences
ACHV
|
2.06 | $ 6.55 | 0.85 % | $ 286 M | USA |
 |
TCR2 Therapeutics
TCRR
|
3.09 | - | - | $ 58.1 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
4.41 | $ 17.02 | 0.98 % | $ 2.29 B |  Canada |
 |
iBio
IBIO
|
7.4 | $ 0.71 | -1.28 % | $ 73.9 M | USA |
 |
ImmuCell Corporation
ICCC
|
2.75 | $ 10.21 | -0.37 % | $ 92.2 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
8.39 | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
Inhibikase Therapeutics
IKT
|
21.8 | $ 1.51 | -5.03 % | $ 148 M | USA |
 |
Immunome
IMNM
|
14 | $ 17.89 | -0.54 % | $ 1.56 B | USA |
|
TFF Pharmaceuticals
TFFP
|
4.89 | - | -60.05 % | $ 125 K | USA |
 |
InMed Pharmaceuticals
INM
|
1.55 | $ 1.57 | 9.03 % | $ 6.54 M | Canada |
 |
Inovio Pharmaceuticals
INO
|
1.48 | $ 0.88 | -1.82 % | $ 41.3 M | USA |
 |
Innoviva
INVA
|
80.3 | $ 21.06 | 1.91 % | $ 1.42 B | USA |
 |
Iovance Biotherapeutics
IOVA
|
4.26 | $ 13.78 | -2.24 % | $ 4.92 M | USA |
 |
Theratechnologies
THTX
|
0.679 | - | - | $ 83.9 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.05 | - | -15.15 % | $ 60.3 M | Britain |
 |
AVEO Pharmaceuticals
AVEO
|
1.77 | - | - | $ 521 M | USA |
 |
Axon Enterprise
AXON
|
1.86 | $ 424.81 | 1.06 % | $ 33.2 B | USA |
 |
Axcella Health
AXLA
|
1.28 | - | -16.42 % | $ 249 M | USA |
 |
Keros Therapeutics
KROS
|
9.69 | $ 11.35 | 0.62 % | $ 422 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.53 | - | - | $ 2.02 B | USA |
 |
Legend Biotech Corporation
LEGN
|
2.37 | $ 20.39 | 5.79 % | $ 7.52 B | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
2.87 | $ 308.16 | 1.53 % | $ 5.96 B | USA |
 |
BridgeBio Pharma
BBIO
|
0.311 | $ 68.11 | -0.65 % | $ 13 B | USA |
 |
Annovis Bio
ANVS
|
4.98 | $ 0.95 | -4.92 % | $ 19.5 M | USA |
 |
Liquidia Corporation
LQDA
|
1.16 | $ 43.75 | 2.58 % | $ 3.77 B | USA |
 |
Tyme Technologies
TYME
|
11.1 | - | 8.07 % | $ 54 M | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
2.39 | $ 1.46 | 2.81 % | $ 530 M | USA |
 |
Mustang Bio
MBIO
|
2.18 | $ 0.36 | -1.89 % | $ 1.77 M | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
0.812 | $ 7.88 | 3.01 % | $ 1.65 B | USA |